摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-hydroxyethyl 3-hydroxypropyl ether | 929-28-2

中文名称
——
中文别名
——
英文名称
2-hydroxyethyl 3-hydroxypropyl ether
英文别名
3-(2-hydroxyethoxy)propan-1-ol;3-(2-hydroxy-ethoxy)-propan-1-ol;2-(3-hydroxypropoxy)ethanol;β-Hydroxyethyl-γ-hydroxypropyl-ether;3-Oxa-1,6-hexadiol;Diaethylenglykol;1-Propanol, 3-(2-hydroxyethoxy)-
2-hydroxyethyl 3-hydroxypropyl ether化学式
CAS
929-28-2
化学式
C5H12O3
mdl
——
分子量
120.148
InChiKey
DSVZDMKYVFDILG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    235-240 °C
  • 密度:
    1.068±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.9
  • 重原子数:
    8
  • 可旋转键数:
    5
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    49.7
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-hydroxyethyl 3-hydroxypropyl ether2,4,6-三甲基吡啶 、 N-(2,2,6,6-tetramethyl-1-oxopiperidin-1-ium-4-yl)acetamide tetrafluoroborate 作用下, 以 二氯甲烷 为溶剂, 反应 4.0h, 以55%的产率得到1,4-dioxepan-2-one
    参考文献:
    名称:
    A Simple and Efficient Synthesis of 1,4- and 1,5-Dioxepan-2-one
    摘要:
    通过对 3-(2-羟乙氧基)丙-1-醇进行区域选择性氧化,实现了 1,4- 和 1,5- 二氧杂环庚烷-2-酮内酯的新型合成。在碱性条件下,当使用氧化铵盐氧化 3-(2-羟乙氧基)丙-1-醇时,观察到了定量氧化酯化反应,从而产生了具有区域选择性的内酯闭环。通过对这种氧化反应进行调整,可以得到收率非常高的 1,4-二氧杂环庚烷-2-酮。
    DOI:
    10.2174/157017809789124849
  • 作为产物:
    描述:
    苄基-一聚乙二醇-丙醇 在 1% Pd/C 、 氢气 作用下, 以 乙醇乙酸乙酯 为溶剂, 以100%的产率得到2-hydroxyethyl 3-hydroxypropyl ether
    参考文献:
    名称:
    A Simple and Efficient Synthesis of 1,4- and 1,5-Dioxepan-2-one
    摘要:
    通过对 3-(2-羟乙氧基)丙-1-醇进行区域选择性氧化,实现了 1,4- 和 1,5- 二氧杂环庚烷-2-酮内酯的新型合成。在碱性条件下,当使用氧化铵盐氧化 3-(2-羟乙氧基)丙-1-醇时,观察到了定量氧化酯化反应,从而产生了具有区域选择性的内酯闭环。通过对这种氧化反应进行调整,可以得到收率非常高的 1,4-二氧杂环庚烷-2-酮。
    DOI:
    10.2174/157017809789124849
点击查看最新优质反应信息

文献信息

  • [EN] BICYCLO[1.1.1]PENTANE INHIBITORS OF DUAL LEUCINE ZIPPER (DLK) KINASE FOR THE TREATMENT OF DISEASE<br/>[FR] INHIBITEURS BICYCLO[1.1.1]PENTANE DE LA DOUBLE FERMETURE À GLISSIÈRE DE LEUCINE KINASE (DLK) DESTINÉS AU TRAITEMENT DE MALADIE
    申请人:UNIV TEXAS
    公开号:WO2018107072A1
    公开(公告)日:2018-06-14
    Disclosed herein are compounds which inhibit the kinase activity of dual leucine zipper (DLK) kinase (MAP3K12), pharmaceutical compositions, and methods of treatment of DLK-mediated diseases, such as neurological diseases that result from traumatic injury to central nervous system and peripheral nervous system neurons (e.g. stroke, traumatic brain injury, spinal cord injury), or that result from a chronic neurodegenerative condition (e.g. Alzheimer's disease, frontotemporal dementia, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, spinocerebellar ataxia, progressive supranuclear palsy, Lewy body disease, Kennedy's disease, and other related conditions), from neuropathies resulting from neurological damage (chemotherapy -induced peripheral neuropathy, diabetic neuropathy, and related conditions) and from cognitive disorders caused by pharmacological intervention (e.g. chemotherapy induced cognitive disorder, also known as chemobrain).
    本文披露了抑制双亮氨酸拉链(DLK)激酶(MAP3K12)激酶活性的化合物、药物组合物以及治疗DLK介导疾病的方法,例如由于对中枢神经系统和外周神经系统神经元的创伤性损伤而导致的神经系统疾病(例如中风、创伤性脑损伤、脊髓损伤),或由于慢性神经退行性疾病(例如阿尔茨海默病、额颞叶痴呆、帕金森病、亨廷顿病、肌萎缩侧索硬化、脊髓小脑共济失调、进行性上行性麻痹、路易体病、肯尼迪病及其他相关疾病)引起的疾病,以及由神经损伤引起的神经病(化疗诱导的周围神经病、糖尿病神经病及相关疾病)和由药物干预引起的认知障碍(例如化疗诱导的认知障碍,也称为化疗脑)。
  • 3-(5-HYDROXY-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF
    申请人:Novartis AG
    公开号:US20200017461A1
    公开(公告)日:2020-01-16
    The present disclosure provides a compound of Formula (I′): or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, wherein R x , X 1 , X 2 , and R 1 are as defined herein, and methods of making and using same.
    本公开提供了化合物Formula (I′)的一种: 或其药用可接受的盐、水合物、溶剂合物、前药、立体异构体或互变异构体,其中R x 、X 1 、X 2 和R 1 如本文所定义,并提供了制备和使用该化合物的方法。
  • PYRIMIDOPYRROLE SPIRO COMPOUNDS AND DERIVATIVES THEREOF AS DNA-PK INHIBITORS
    申请人:Medshine Discovery Inc.
    公开号:EP4063371A1
    公开(公告)日:2022-09-28
    Provided are a class of DNA-PK inhibitor, and specifically, a compound represented by formula (III) or a pharmaceutically acceptable salt thereof, and use thereof in the preparation of DNA-PK inhibitor-related drugs.
    提供了一类DNA-PK抑制剂,具体而言,是由公式(III)表示的化合物或其药学上可接受的盐,以及在制备DNA-PK抑制剂相关药物时的使用。
  • Effect of the Thermal History on the Thermal and Rheological Behavior of a Thermotropic Polyester
    作者:Jorge Ressia、Lidia Quinzani、Enrique Valles、Pablo Bello、Antonio Bello
    DOI:10.1080/15421400490487416
    日期:2004.1.1
    The biphasic behavior and phase transitions of a thermotropic mainchain liquid crystalline polyester, the poly(oxytrimetilen-etilen glycol p,p'-bibenzoate), was studied by X-ray diffractometry, differential scanning calorimetry ( DSC), and rotational rheometry. The liquid crystalline mesophase structure of the polymer evolves from Smectic C to Smectic A at around 100degreesC and changes to the isotropic state at about 200degreesC. The annealing of polymer samples at different temperatures within the smectic-isotropic transition gives rise to double endotherm and exotherm peaks on the heating and cooling DSC traces. These peaks are attributed to the preferential segregation of the lower molecular weight molecules from the liquid crystalline to the isotropic phase in the biphasic zone. The rheological studies are consistent with this result. The dynamic moduli measured at constant frequency in temperature ramps using polymer samples with different thermal histories reveal that the type of annealing processes applied in the biphasic zone generates different evolution of the rheological data.
  • Borgen,G. et al., Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry, 1979, vol. 33, p. 15 - 21
    作者:Borgen,G. et al.
    DOI:——
    日期:——
查看更多